GAM
ESPR

Gotham Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Gotham Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$571K Buy
+208,451
New +$660K ﹤0.01% 1456
2025
Q1 		– Sell
-11,977
Closed -$26.3K – 1587
2024
Q4 		$26.3K Sell
11,977
-11,889
-50% -$27.7K ﹤0.01% 1420
2024
Q3 		$39.4K Buy
23,866
+8,595
+56% +$17.4K ﹤0.01% 1395
2024
Q2 		$33.9K Buy
+15,271
New +$35.9K ﹤0.01% 1401
2020
Q4 		– Sell
-20,574
Closed -$765K – 1030
2020
Q3 		$765K Buy
+20,574
New +$815K 0.02% 624
2019
Q3 		– Sell
-11,416
Closed -$531K – 1123
2019
Q2 		$531K Buy
+11,416
New +$536K 0.01% 788

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return